(Mercaptoethyl)ammonium hydrogen tartrate
CAS: 27761-19-9
Ref. 3D-FM171255
1g | A consultar | ||
2g | A consultar | ||
5g | A consultar | ||
250mg | A consultar | ||
500mg | A consultar |
Información del producto
- 2,3-Dihydroxybutanedioate
- 2-Aminoethanethiol
- Cystagon
- Cysteamine Bitartrate
- Ethanethiol, 2-amino-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- Ethanethiol, 2-amino-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
- Ethanethiol, 2-amino-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt)
- Ethanethiol, 2-amino-, hydrogen tartrate
- Ethanethiol, 2-amino-, tartrate (1:1) (salt)
- Mercamine bitartrate
- Ver más sinónimos
- Mercaptoethylamine bitartrate
- Procysbi
- Rp 103
- Rp 104
- β-Mercaptoethylamine bitartrate
- β-Mercaptoethylamine hydrogen tartrate
- β-Mercaptoethylamine hydrotartrate
The experimental model of the controlled-release preparation of (mercaptoethyl)ammonium hydrogen tartrate is based on the hypothesis that a high resistance to hepatic steatosis can be achieved by a prolonged release of cysteamine. The drug was administered enterically, and it was found that the concentration in the portal vein is higher than in the portal vein. Cysteamine enters into liver cells and inhibits protein synthesis. Cysteamine has been shown to have an effect on infectious diseases such as cystinosis, and sodium citrate reduces the toxicity of cysteamine.
Propiedades químicas
Consulta técnica sobre: 3D-FM171255 (Mercaptoethyl)ammonium hydrogen tartrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.